9.6 Hyponatremia, Hypernatremia & Water Balance
Key Takeaways
Hypernatremia and hyponatremia are enumerated under both water and electrolyte balance in nephrology and posterior pituitary disorders in endocrinology.
Serum osmolality first separates true hypotonic hyponatremia from pseudohyponatremia and from hypertonic causes such as hyperglycemia.
Urine osmolality and urine sodium then separate primary polydipsia, appropriate ADH suppression, hypovolemia and the syndrome of inappropriate antidiuresis.
Correction should not exceed roughly 8 mEq/L in 24 hours in patients at risk, to avoid osmotic demyelination syndrome.
Severe symptomatic hyponatremia with seizures or coma is treated with hypertonic saline boluses regardless of chronicity.
Fluid, electrolyte, acid-base disorders, and nephrolithiasis represent some of the most analytically rigorous topics on the ABIM Internal Medicine board examination. Clinical competence requires a systematic, formula-driven approach to deciphering mixed acid-base disorders, navigating strict correction speed limits in dysnatremias to prevent catastrophic neurologic injury, managing hyperkalemic emergencies, and formulating evidence-based stone prevention regimens.
1. Stepwise Diagnostic Approach to Hyponatremia
Hyponatremia (Serum Sodium < 135 mEq/L) represents a relative excess of water in relation to sodium. Diagnostic evaluation must follow a strict three-step sequence:
Step 1: Determine Serum Osmolality
- Hypertonic Hyponatremia (Serum Osm > 295 mOsm/kg): Caused by unmeasured effective osmoles drawing intracellular water into the extracellular space. Most commonly severe hyperglycemia or IV mannitol. (Note: For glucose >400 mg/dL, use a correction factor of 2.0 or 2.4).
- Isotonic Hyponatremia / Pseudohyponatremia (Serum Osm 275–295 mOsm/kg): Laboratory artifact caused by excessive lipids or proteins displacing the aqueous phase of plasma when measured by indirect ion-selective electrodes. Seen in severe hypertriglyceridemia (triglycerides >1500 mg/dL) or paraproteinemia / multiple myeloma.
- Hypotonic Hyponatremia (Serum Osm < 275 mOsm/kg): True hypotonic hyponatremia; proceed to Step 2.
Step 2: Assess Clinical Extracellular Fluid (ECF) Volume Status
-
Hypovolemic Hypotonic Hyponatremia (Total Body Na Loss > Total Body Water Loss):
- Physical Exam: Orthostatic hypotension, tachycardia, dry mucous membranes, decreased skin turgor, flat neck veins.
- Urine Sodium < 20 mEq/L (FeNa < 1%): Extrarenal sodium losses (vomiting, diarrhea, third-spacing, burns).
- Urine Sodium > 20 mEq/L (FeNa > 1%): Renal sodium losses (thiazide diuretics, cerebral salt wasting, mineralocorticoid deficiency / primary adrenal insufficiency [Addison disease with high K+ and low cortisol]).
- Treatment: Volume resuscitation with 0.9% Isotonic Saline.
-
Euvolemic Hypotonic Hyponatremia (Normal Total Body Na, Moderately Increased Water):
- Physical Exam: No peripheral edema, no ascites, normal JVP, normal BP.
- Syndrome of Inappropriate ADH Secretion (SIADH):
- Diagnostic Criteria: Hypotonic hyponatremia, high urine osmolality (Urine Osm > 100 mOsm/kg, typically >300), high urine sodium (Urine Na > 40 mEq/L), low serum uric acid (<4.0 mg/dL), low BUN (<10 mg/dL), and normal thyroid/adrenal/renal function.
- Etiologies: Malignancies (Small Cell Lung Cancer [SCLC], head/neck tumors), CNS pathology (stroke, subdural hematoma, meningitis), Pulmonary disease (pneumonia, TB), Drugs (SSRIs, SNRIs, Carbamazepine, Oxcarbazepine, Cyclophosphamide, NSAIDs).
- Treatment: Fluid restriction (<800–1000 mL/day) is first-line; oral salt tablets + low-dose loop diuretic (Furosemide); oral urea; or Vasopressin V2 Receptor Antagonists (Vaptans: Tolvaptan 15–30 mg daily) for refractory euvolemic hyponatremia (avoid fluid restriction during vaptan therapy; do not exceed 30 days due to hepatotoxicity risk).
- Low Solute Intake Syndromes (Urine Osm < 100 mOsm/kg): Psychogenic Polydipsia (massive water intake overwhelming normal renal diluting capacity), Beer Potomania, "Tea-and-Toast" diet.
- Endocrine: Severe hypothyroidism, Secondary adrenal insufficiency (ACTH deficiency -> cortisol deficiency impairs free water excretion without mineralocorticoid loss).
-
Hypervolemic Hypotonic Hyponatremia (Total Body Na Excess < Total Body Water Excess):
- Physical Exam: Peripheral pitting edema, ascites, elevated JVP, pulmonary crackles.
- Urine Sodium < 20 mEq/L: Congestive Heart Failure, Cirrhosis, Nephrotic Syndrome (decreased effective arterial blood volume triggers non-osmotic ADH release and RAAS activation).
- Urine Sodium > 20 mEq/L: Advanced Acute Kidney Injury or ESKD.
- Treatment: Dietary sodium and fluid restriction, loop diuretics, neurohormonal blockade.
2. Emergency Management of Dysnatremias & Osmotic Demyelination Syndrome
Critical Correction Speed Limits in Hyponatremia
- Acute Symptomatic Hyponatremia (Duration < 48 hours with seizures, coma, respiratory arrest, herniation):
- Administer 3% Hypertonic Saline (513 mEq/L) 100–150 mL IV bolus over 10 to 20 minutes.
- May repeat up to 2 times PRN to rapidly elevate serum sodium by 4 to 6 mEq/L within 1 to 2 hours, which rapidly reduces cerebral edema and halts active herniation.
- Chronic Hyponatremia (Duration > 48 hours or unknown):
- In chronic hyponatremia, brain cells extrude organic osmolytes (myo-inositol, taurine, glutamate) to adapt to hypotonicity. Rapid sodium correction causes sudden hypertonic shrinkage of brain parenchyma.
- STRICT MAXIMUM LIMIT: <= 8 mEq/L total increase within 24 hours (and <= 14–16 mEq/L in 48 hours).
- High-Risk Patients: In patients with advanced cirrhosis, chronic alcoholism, malnutrition, hypokalemia, or baseline sodium < 105 mEq/L, target 4 to 6 mEq/L per 24 hours (never exceed 8 mEq/L).
Osmotic Demyelination Syndrome (ODS / Central Pontine Myelinolysis)
- Pathophysiology: Overly rapid correction (>8–10 mEq/L/24h) strips water from oligodendrocytes, triggering apoptosis and demyelination of the central pontine white matter tracts and extrapontine basal ganglia.
- Clinical Presentation: Classically biphasic. The patient initial improves as sodium rises, but 2 to 6 days later develops progressive dysarthria, dysphagia, horizontal gaze paralysis, spastic quadriparesis, encephalopathy, and irreversible "Locked-in" Syndrome.
- Rescue Therapy for Overcorrection: If the sodium rises by >8 mEq/L in 24 hours, immediately stop all saline infusions, administer IV Dextrose 5% in Water (D5W) at 3 mL/kg/h, and administer Subcutaneous Desmopressin (DDAVP) 1 to 2 µg every 6 to 8 hours to arrest free water diuresis and safely re-lower serum sodium back within target limits.
A 72-year-old woman with generalized anxiety disorder treated with Sertraline 100 mg daily presents to the clinic with 1 week of lethargy, mild confusion, and unsteady gait. She takes no diuretics or NSAIDs. Vital signs show blood pressure 126/74 mmHg without orthostasis, heart rate 72 bpm, respiratory rate 14/min, and JVP is 6 cm H2O with no peripheral edema. Laboratory evaluation reveals: Serum Sodium 118 mEq/L, Serum Potassium 4.0 mEq/L, Serum Osmolality 248 mOsm/kg (normal: 275–295), Urine Osmolality 460 mOsm/kg, Urine Sodium 54 mEq/L, Serum Uric Acid 2.8 mg/dL (low), and normal serum TSH and morning cortisol levels. What is the most appropriate management plan?
Administer 0.9% normal saline at 150 mL/h and continue Sertraline
Administer 3% hypertonic saline as a 500-mL bolus to correct serum sodium to 135 mEq/L within 12 hours
Discontinue Sertraline, initiate fluid restriction (<800–1000 mL/day), and ensure serum sodium correction does not exceed 8 mEq/L in 24 hours
Prescribe oral Demeclocycline and encourage free water intake >3 L/day
Sections you finish are checked off in the contents.